Tuesday morning Abiomed announced that its Impella RP device, which provides temporary support for patients with right ventricular failure, received CE mark approval in Europe. This is a positive development for the company, and while we do not expect an immediate bump in sales. The Impella RP is similar to Abiomed’s flagship left-side Impella device…